INTCO medical participates in public welfare activities and actively fulfills its social responsibilities.

NEWS CENTER

Home News Center INTCO News

INTCO Medical 2024 ESG Report

2025.05.07

Table of Contents

    On April 23, 2024, INTCO Medical, recognized globally as the largest latex-free disposable gloves manufacturer, released its 2024 Environmental, Social, and Governance (ESG) Report—the fourth disclosure since the company began prioritizing ESG transparency. The report highlights INTCO’s commitment to driving industry transformation through technological innovation, embracing green practices, and fostering global collaboration under its mission. As a leader in medical consumables, INTCO demonstrates how sustainability and business excellence coexist, setting benchmarks for the healthcare industry.

     

    Environmental Stewardship: Redefining Sustainable Manufacturing

     

    INTCO Medical’s environmental initiatives focus on resource efficiency and low-carbon operations. In 2024, the company achieved a 20.7% reduction in carbon emissions per glove (20.41 grams per glove) and an 11.02% reduction in water consumption (0.21 liters per glove), reflecting ongoing investments in eco-friendly technologies. The company also generated 3,538,596.60 kWh of solar power, while carbon emissions from its rehabilitation and physiotherapy products were capped at 5,800 tons of CO₂e.

     

    INTCO Medical 2024 ESG Report

     

    Social Impact: Cultivating Inclusive Growth

     

    INTCO prioritizes its workforce as a core asset, fostering a diverse and inclusive culture. With 10,982 employees globally, the company boasts a 60.23% female workforce and 33.6% female representation in management, including 22.7% in C-suite roles. The company invested ¥398 million in R&D, with 1,202 researchers (10.95% of staff) driving innovation in latex-free glove technology and medical devices.

     

    Employee development is central to INTCO’s social strategy, with 100% training coverage and an average of 36.02 hours of training per employee in 2024. The company also prioritizes accessibility, employing 162 ethnic minority staff and 120 persons with disabilities, while STEM roles feature 228 female employees. Through monthly team-building activities and a “competition and merit” promotion system, INTCO enhances employee engagement and career growth, ensuring a motivated workforce that powers its manufacturing leadership.

     

    Governance Excellence: Transparency and Accountability

     

    INTCO Medical maintains rigorous corporate governance to uphold stakeholders’ trust. The board of directors includes 42.86% independent directors and 42.86% female directors, ensuring diverse oversight. In 2024, the company held 5 shareholder meetings, 9 board meetings, and 10 committee meetings, addressing 75+ resolutions to drive strategic clarity.

     

    Risk management is a cornerstone of INTCO’s governance, with 5 anti-corruption training sessions reaching over 1,000 employees. The company’s Supplier Relationship Management (SRM) system monitors 3,939 suppliers (3,900 rated A), ensuring ethical sourcing and sustainability. Through 198 supplier trainings and 268 technical seminars, INTCO strengthens its global supply chain, aligning partners with its ESG goals.

     

    INTCO Medical has launched a unique "INTCO YOUNG" program

     

    ESG Recognition: Awards and Accreditations

     

    INTCO’s ESG leadership has been widely acknowledged, including a WIND Rating A, an MSCI ESG Rating of BBB, and the EcoVadis Committed Badge. The company also achieved WRAP and BSCI certifications, validating its ethical manufacturing practices. In 2024, INTCO received 16 ESG awards, such as “Top 20 ESG A-Share Medical Device Companies” and “ESG Golden Bull Award for Governance,” reflecting its holistic approach to sustainability.

     

    Innovation and Community Commitment

     

    As the largest latex-free disposable gloves manufacturer, INTCO invests in R&D to drive product excellence. In 2024, the company launched 55 new products (a 197% increase year-over-year), expanded into 5 new markets (food processing, e-commerce, etc.), and secured 33 patent approvals (282 total), including innovations in synthetic latex gloves for allergy-free protection.

     

    Community impact is equally vital, with the Shanghai INTCO Public Welfare Foundation donating ¥2.82 million in 2024 to poverty alleviation, education, and disaster relief. These efforts exemplify INTCO’s mission to make healthcare accessible while uplifting vulnerable communities.

     

    Looking Ahead

     

    In 2025, INTCO Medical will deepen its ESG commitments, leveraging renewable energy, digital supply chain management, and inclusive innovation to support “Healthy China” and global sustainability goals. As a trusted partner in latex-free gloves and medical solutions, the company aims to collaborate with stakeholders to build a healthier, greener future, proving that leadership in manufacturing can coexist with responsibility to the planet and society.

     

    Talk to Our Product
    Experts Today!

    Contact Us